For Immediate Release
Chicago, IL – June 11, 2020 – Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets. Stocks recently featured in the blog include: Apple AAPL, Wells Fargo WFC, BHP Group BHP, Amazon.com AMZN and Marriott International MAR.
Here are highlights from Wednesday’s Analyst Blog:
Top Research Reports for Apple, Wells Fargo and BHP Group
The Zacks Research Daily presents the best research output of our analyst team. Today’s Research Daily features new research reports on 16 major stocks, including Apple, Wells Fargo and BHP Group. These research reports have been hand-picked from the roughly 70 reports published by our analyst team today.
You can see all of today’s research reports here >>>
Apple’s shares have outperformed the S&P 500 over the past year (+76.6% vs. +11.1%). The Zacks analyst believes that the company is benefiting from a continued momentum in the Services segment, driven by strong App Store sales and the robust adoption of Apple Music and Apple Pay.
Non-iPhone devices, particularly Apple Watch and AirPod, are other notable drivers in the long haul. However, iPhone sales are expected to remain bleak in the near term due to the negative impact of the coronavirus. In fact, the company expects iPhone and Wearables business revenues for the fiscal second quarter to be worse on a year-over-year basis than the fiscal first quarter.
On the contrary, iPad and Mac revenues are expected to improve but lower economic activity will hurt AppleCare and advertising businesses. The company didn’t provide any guidance due to the pandemic-triggered uncertainty.
Shares of Wells Fargo have lost -38.6% over the past six months against the Zacks Major Regional Banks industry’s fall of -22%. The Zacks analyst believes that the company’s investment in the businesses to enhance compliance and risk-management capability seem encouraging.
However, the company’s earnings surprise history remains unimpressive, having surpassed the Zacks Consensus Estimate in only one of the trailing four quarters. Wells Fargo’s revenues remain under pressure due to lower interest rates and volatile fee income. Also, rising costs in providing benefits to clients amid coronavirus concerns might curb bottom-line growth. Legal hassles also remain a concern.
Moreover, streamlining activities along with rising loans and deposits balance remain tailwinds. Also, debt level postion remains manageable. Recently, at a virtual conference, the company provided a grim outlook for the current quarter.
BHP Group’s shares have gained +47.4% over the past three months against the Zacks SMining – Miscellaneous industry’s rise of +37.7%. The Zacks analyst believes that the company will benefit from the recent surge in iron and copper prices. The consensus estimate for earnings for the current fiscal has undergone positive revisions lately.
BHP Group’s copper and iron ore production increased year over year in the nine month period ended Mar 31, 2020, while petroleum, metallurgical coal, energy coal and nickel production declined. The company affirmed petroleum, iron ore and metallurgical coal production and cost guidance for fiscal 2020 despite the pandemic.
Its strong cash flow and focus on lowering debt will help it sail through these turbulent times. The company has six major projects under development in petroleum, copper, iron ore and potash, which will drive growth in the long run. However, slowdown in global growth on account of the pandemic remains a headwind in the near term.
Other noteworthy reports we are featuring today include Amazon.com and Marriott International.
Breakout Biotech Stocks with Triple-Digit Profit Potential
The biotech sector is projected to surge beyond $775 billion by 2024 as scientists develop treatments for thousands of diseases. They’re also finding ways to edit the human genome to literally erase our vulnerability to these diseases.
Zacks has just released Century of Biology: 7 Biotech Stocks to Buy Right Now to help investors profit from 7 stocks poised for outperformance. Our recent biotech recommendations have produced gains of +50%, +83% and +164% in as little as 2 months. The stocks in this report could perform even better.
See these 7 breakthrough stocks now>>
Media Contact
Zacks Investment Research
800-767-3771 ext. 9339
Past performance is no guarantee of future results. Inherent in any investment is the potential for loss. This material is being provided for informational purposes only and nothing herein constitutes investment, legal, accounting or tax advice, or a recommendation to buy, sell or hold a security. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. It should not be assumed that any investments in securities, companies, sectors or markets identified and described were or will be profitable. All information is current as of the date of herein and is subject to change without notice. Any views or opinions expressed may not reflect those of the firm as a whole. Zacks Investment Research does not engage in investment banking, market making or asset management activities of any securities. These returns are from hypothetical portfolios consisting of stocks with Zacks Rank = 1 that were rebalanced monthly with zero transaction costs. These are not the returns of actual portfolios of stocks. The S&P 500 is an unmanaged index. Visit http://www.zacks.com/performancefor information about the performance numbers displayed in this press release.
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
To read this article on Zacks.com click here.
Zacks Investment Research